Integrated Annual Report

Overview

The report presents Torrent Pharma's third Integrated Annual Report for FY 2022-23, combining financial, ESG, BRSR and governance disclosures. It highlights 13% revenue growth to INR 9,620 crores, a 3.74% reduction in Scope 1 and Scope 2 emissions, and expansion of renewable-energy initiatives. Sustainability disclosures cover materiality, human capital, water stewardship, waste management, CSR, and a Board-level sustainability committee.

Document

Report type: Integrated Report
Class: Embedded
Scope: Full report
Fiscal year: 2022-2023
Period: 1 April 2022 – 31 March 2023
Language: English
Pages
File size

Standards

GRI
SASB
TCFD
ISSB
ESRS
Integrated Reporting Framework
GHG Protocol
EU Taxonomy
CDP

Ratings

GRI level

Materiality

Assessment
Basis

Assurance

Statement included

Data Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services